Poorva Bindal to Immunotherapy, Adoptive
This is a "connection" page, showing publications Poorva Bindal has written about Immunotherapy, Adoptive.
Connection Strength
1.191
-
Bindal P, Patell R, Chiasakul T, Lauw MN, Ko A, Wang TF, Zwicker JI. A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. J Thromb Haemost. 2024 Jul; 22(7):2071-2080.
Score: 0.783
-
Gerber JM, Dehdashtian E, Hu G, Gregoire C, Borie D, Bindal P, Cerny J, Geara A, Schett G, Caricchio R. Successful autologous CD19 CAR T cell therapy following severe lupus flare during immunosuppressive washout in refractory lupus nephritis. Lupus Sci Med. 2025 Nov 19; 12(2).
Score: 0.219
-
Andersen M, Bindal P, Michaels P, Elavalakanar P, Liegel J, Dias A, Arnason J, Patell R. Clonal myeloid disorders following CAR T-cell therapy. Ann Hematol. 2023 12; 102(12):3643-3645.
Score: 0.189